These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 9684948)

  • 1. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
    Laakmann G; Dienel A; Kieser M
    Phytomedicine; 1998 Dec; 5(6):435-42. PubMed ID: 23196026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
    BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU; Arnoldt KH; Hübner WD
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St John's wort as an antidepressant.
    De Smet PA; Nolen WA
    BMJ; 1996 Aug; 313(7052):241-2. PubMed ID: 8704522
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
    Schellenberg R; Sauer S; Dimpfel W
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():44-53. PubMed ID: 9684947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's wort for depression--an overview and meta-analysis of randomised clinical trials.
    Linde K; Ramirez G; Mulrow CD; Pauls A; Weidenhammer W; Melchart D
    BMJ; 1996 Aug; 313(7052):253-8. PubMed ID: 8704532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of St. John's Wort for depression in primary care - a non-interventional study].
    Musselmann B; Rychlik R; Burkart M
    MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study.
    Harrer G; Hübner WD; Podzuweit H
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S24-8. PubMed ID: 7857503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.
    Miller AL
    Altern Med Rev; 1998 Feb; 3(1):18-26. PubMed ID: 9600023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
    Trautmann-Sponsel RD; Dienel A
    J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should you take St. John's Wort?
    Nierenberg A
    Health News; 1998 Apr; 4(5):4-5. PubMed ID: 9563296
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A; Fischer H; Römer A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.